| Description | The product SIRGT52064WQ-2F is a type of small interfering RNA (siRNA) that targets PERM1 gene and regulates the expression of gene. The siRNA interferes with the expression of PERM1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNAThe product SIRGT52064WQ-2F is a type of small interfering RNA (siRNA) that targets PERM1 gene and regulates the expression of gene. The siRNA interferes with the expression of PERM1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-deoxy-2_-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Bifidobacterium is Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They wre originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In Bifidobacterium is Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They wre originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In humans, Bifidobacterium resides within the GI tract, from birth to old age. Disturbances in the microbiota are linked to an ever-growing number of immune-linked disease states including IBD, atopic allergy, arthritis, and obesity. Therefore, there is a significant interest in treating these diseases through microbial or "probiotic" supplementation of patients, including Bifidobacterium. Data from mouse models and clinical trials indicate that Bifidobacterium may have beneficial effects for treating and preventing immune-linked diseases, including gut-associated and systemic conditions. Bifidobacterium have been commercially exploited as probiotic agents due to their associated health benefits and GRAS.... Read More | This product GTTS-WQ7127MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the monoclonal antibody that targets LHCGR gene. The antibody can be applied in Controlled Ovarian Stimulation (COS) research. | This product GTTS-WK5967MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the CD40 protein. This product can be used in -related researches. | SARS-CoV-2 Inactivated Virus Particles is chemically modifie to be non-infectious intact viral particles. The inactivation was verified in a standard microbiological growth protocol. Based on our in-house RT-PCR assay to detect the N proteins, it indicates that our product includes 1,000,000 copies SARS-CoV-2 Inactivated Virus Particles is chemically modifie to be non-infectious intact viral particles. The inactivation was verified in a standard microbiological growth protocol. Based on our in-house RT-PCR assay to detect the N proteins, it indicates that our product includes 1,000,000 copies per mL.... Read More |